PMID: 6105478Aug 16, 1980Paper

In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy

Lancet
D S AlbertsT E Moon

Abstract

95 clinical trials of anticancer drugs were done in 40 patients with advanced ovarian cancer who had undergone an in-vitro soft-agar human tumour stem-cell assay for drug sensitivity. In the 95 clinical trials, 13 of 21 patients responded clinically to drugs predicted to be effective in vitro, while in 73 of 74 instances in which drug resistance had been predicted in vitro there was no response to treatment. 2 patients achieved a complete remission of 1 and 12+ months and 11 had partial remissions lasting a median of four months. Prediction of in-vitro resistance was 99% accurate. The 62% complete or partial remission rate to agents with proven in-vitro efficacy was achieved in extensively pretreated ovarian cancer patients who were unlikely to respond to empirically chosen secondary agents. The human tumour stem-cell assay, in which ovarian tumour colony-forming units are grown in a two-layer agar-culture system incorporating tests for drug sensitivity or resistance, can be effectively used to plan a suitable chemotherapy regimen for ovarian cancer patients.

References

Jun 15, 1978·The New England Journal of Medicine·S E SalmonT E Moon
Mar 1, 1977·Gynecologic Oncology·C R StanhopeF Rutledge
Jul 29, 1977·Science·A W Hamburger, S E Salmon
Oct 26, 1972·The New England Journal of Medicine·C M BagleyV T DeVita

❮ Previous
Next ❯

Citations

Jan 1, 1985·Journal of Cancer Research and Clinical Oncology·D FanS Fan
Jan 1, 1984·Journal of Cancer Research and Clinical Oncology·R M Canetta, S K Carter
Jan 1, 1984·Journal of Cancer Research and Clinical Oncology·D FanL R Morgan
May 1, 1986·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·S U Hildebrand-Zanki, D H Kern
Jul 19, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Jan LankelmaBob Kooi
Apr 1, 1984·European Journal of Obstetrics, Gynecology, and Reproductive Biology·R H VerheijenP Kenemans
May 11, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S NakadaS Nozawa
Jan 7, 2016·Frontiers in Oncology·Manfred Volm, Thomas Efferth
Jan 1, 1991·Critical Reviews in Clinical Laboratory Sciences·A B Cramer, E A Woltering
Jan 1, 1990·Gynecologic Oncology·L CarenzaR Prosperi Porta
Feb 1, 1985·European Journal of Cancer & Clinical Oncology·M RozencweigJ Klastersky
Jan 1, 1985·European Journal of Cancer & Clinical Oncology·R WillemzeH Journée
Jan 1, 1991·Journal of Clinical Laboratory Analysis·R M Hoffman
Oct 1, 1985·Statistics in Medicine·E L KornD H Kern
May 1, 1987·International Journal of Cell Cloning·D D Von Hoff
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John P Fruehauf, David S Alberts
Jan 1, 1985·Journal of Neuro-oncology·G UnsgaardR Ringkjøb
May 27, 2014·American Society of Clinical Oncology Educational Book·Elise C Kohn
Jan 1, 1981·Cancer Chemotherapy and Pharmacology·D S AlbertsF L Meyskens
Sep 15, 1983·International Journal of Cancer. Journal International Du Cancer·F L MeyskensS E Salmon
Jul 15, 1983·International Journal of Cancer. Journal International Du Cancer·H T RupniakB T Hill
Jun 15, 1981·International Journal of Cancer. Journal International Du Cancer·G L Floersheim, J Torhorst
Jan 26, 2013·British Journal of Haematology·Martin J S DyerSalvador Macip
Jan 1, 1985·Cancer Investigation·A R Hanauske, D D Von Hoff
Oct 15, 1981·International Journal of Cancer. Journal International Du Cancer·K M TveitA Pihl
Mar 1, 1988·Journal of Surgical Oncology·V K SondakD H Kern

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.